List of insiders holdings for GERON CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
HARLEY CALVIN VP, CSO Telomerase Tech | 2009-06-01 21:24:34 | 2,258,451 0 | 2,258,451 | Form 4 |
SCARLETT JOHN A Chairman, President and CEO | 2024-06-07 16:10:06 | 1,000,000 0 | 1,000,000 | Form 4 |
WALKER JOHN PETER Director | 2009-01-30 21:12:26 | 886,087 0 | 886,087 | Form 4 |
OKARMA THOMAS President and CEO | 2010-07-13 20:13:37 | 774,560 0 | 774,560 | Form 4 |
ROSENFIELD STEPHEN EVP, Chief Legal Off & Sec | 2022-02-18 18:07:42 | 750,000 0 | 750,000 | Form 4 |
Rizo Aleksandra EVP, Chief Medical Officer | 2022-02-18 18:05:14 | 750,000 0 | 750,000 | Form 4 |
EARP DAVID SVP, Corp Transactions | 2012-06-01 20:15:12 | 467,406 0 | 467,406 | Form 4 |
Parker Craig C EVP, Corp Dev & Sci Affairs | 2014-02-12 20:30:23 | 400,000 0 | 400,000 | Form 4 |
BARKAS ALEXANDER E Director | 2011-05-24 21:07:29 | 353,122 0 | 353,122 | Form 4 |
Kapur Anil EVP, Corp Strategy & CCO | 2024-06-12 16:05:04 | 328,125 0 | 328,125 | Form 4 |
BEHRS MELISSA KELLY EVP, Chief Business Officer | 2021-02-04 19:45:30 | 300,000 0 | 300,000 | Form 4 |
Benedetti Fabio M SVP, Chief Med Off, Oncology | 2009-06-01 21:22:27 | 265,560 0 | 265,560 | Form 4 |
STEMPEL WILLIAM VP and General Counsel | 2004-06-01 17:17:39 | 260,480 0 | 260,480 | Form 4 |
Bloom Olivia Kyusuk EVP, Chief Financial Officer | 2023-09-21 20:31:15 | 250,000 0 | 250,000 | Form 4 |
Samuels Scott Alan EVP, Chief Legal Officer | 2024-06-07 16:10:05 | 250,000 0 | 250,000 | Form 4 |
ROBERTSON MICHELLE EVP, Chief Financial Officer | 2024-06-07 16:10:03 | 250,000 0 | 250,000 | Form 4 |
MERIX BIOSCIENCE INC 10% Owner | 2004-11-12 07:58:28 | 221,300 0 | 221,300 | Form 13G |
COOPER GRAHAM K EVP, Bus Dev & CFO | 2012-05-18 20:05:38 | 200,000 0 | 200,000 | Form 4 |
FRITZKY EDWARD V Director | 2013-05-24 19:09:01 | 186,511 0 | 186,511 | Form 4 |
McDonald John F Director | 2024-05-10 16:05:24 | 180,000 0 | 180,000 | Form 4 |
Bir Dawn Carter Director | 2024-05-10 16:05:22 | 180,000 0 | 180,000 | Form 4 |
Aggarwal Gaurav Director | 2024-05-10 16:05:21 | 180,000 0 | 180,000 | Form 4 |
O'Farrell Elizabeth G. Director | 2024-05-10 16:05:07 | 180,000 0 | 180,000 | Form 4 |
Molineaux Susan Director | 2024-05-10 16:05:15 | 180,000 0 | 180,000 | Form 4 |
KILEY THOMAS Director | 2013-05-24 19:10:16 | 171,911 0 | 171,911 | Form 4 |
Spiegel Robert J. Director | 2024-10-01 16:05:02 | 170,185 0 | 170,185 | Form 4 |
EASTHAM KARIN Director | 2023-01-17 19:01:10 | 109,047 0 | 109,047 | Form 4 |
Feller Faye EVP, Chief Medical Officer | 2024-06-12 16:05:08 | 87,500 0 | 87,500 | Form 4 |
ZENNER PATRICK J Director | 2010-05-21 21:10:16 | 84,960 0 | 84,960 | Form 4 |
HOMCY CHARLES J Director | 2011-05-13 20:02:01 | 72,751 0 | 72,751 | Form 4 |
Huh Hoyoung Director | 2018-05-17 16:42:56 | 70,000 0 | 70,000 | Form 4 |
Kelsey Stephen Michael EVP, R&D, Chief Med Officer | 2013-05-07 21:23:46 | 62,272 0 | 62,272 | Form 4 |
BRADBURY DANIEL Director | 2019-04-01 19:55:22 | 0 51,323 | 51,323 | Form 4 |
LEBKOWSKI JANE Former SVP, CSO | 2012-02-14 17:09:24 | 0 38,712 | 38,712 | Form 5 |
GREENWOOD DAVID Former President and CFO | 2012-02-14 17:10:03 | 0 28,596 | 28,596 | Form 5 |
Hofstaetter Thomas Director | 2015-03-19 19:27:58 | 26,564 0 | 26,564 | Form 4 |
Spink Katharine E. Former SVP Alliance Mgmt & Ops | 2012-02-14 17:11:15 | 0 15,803 | 15,803 | Form 5 |
Nallicheri Melanie I SVP Corp Dev | 2012-02-14 17:10:29 | 0 10,015 | 10,015 | Form 5 |
Colowick Alan President, Oncology | 2008-01-04 20:54:56 | 0 3,028 | 3,028 | Form 4 |
STEIN ROBERT B Director | 2003-12-02 16:24:28 | 625 0 | 625 | Form 4 |
LAWLIS V BRYAN Director | 2024-05-17 16:05:30 | 0 0 | 0 | Form 4 |
GRETHLEIN ANDREW J EVP, Chief Operating Officer | 2024-07-10 16:05:04 | 0 0 | 0 | Form 4 |
Ziegler James EVP, Chief Commercial Officer | 2024-09-09 16:35:06 | 0 0 | 0 | Form 3 |
Eid Joseph EVP, Research and Development | 2024-11-12 16:05:19 | 0 0 | 0 | Form 3 |